Weir Hannah K, Johnson Christopher J, Mariotto Angela B, Turner Donna, Wilson Reda J, Nishri Diane, Ward Kevin C
Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA (HKW, RJW); Cancer Data Registry of Idaho, Boise, ID (CJJ); Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Bethesda, MD (ABM); Cancer Care Manitoba, Winnipeg, MB, Canada (DT); Cancer Care Ontario, Toronto, ON, Canada (DN); Georgia Center for Cancer Statistics, Emory University, Atlanta, GA (KCW).
J Natl Cancer Inst Monogr. 2014 Nov;2014(49):198-209. doi: 10.1093/jncimonographs/lgu018.
Follow-up procedures vary among cancer registries in North America. US registries are funded by the Surveillance, Epidemiology, and End Results (SEER) Program and/or the National Program of Cancer Registries (NPCR). SEER registries ascertain vital status and date of last contact to meet follow-up standards. NPCR and Canadian registries primarily conduct linkages with local and national death records to ascertain deaths. Data on patients diagnosed between 2002 through 2006 and followed through 2007 were obtained from 51 registries. Registries that met follow-up standards or, at a minimum, conducted linkages with local and national death records had comparable age-standardized five-year survival estimates (all sites and races combined): 63.9% SEER, 63.1% NPCR, and 62.6% Canada. Estimates varied by cancer site. Survival data from registries using different follow-up procedures are comparable if death ascertainment is complete and all nondeceased patients are presumed to be alive to the end of the study period.
北美各癌症登记机构的随访程序各不相同。美国的登记机构由监测、流行病学和最终结果(SEER)计划和/或国家癌症登记计划(NPCR)资助。SEER登记机构确定生命状态和最后一次接触日期,以符合随访标准。NPCR和加拿大的登记机构主要与地方和国家死亡记录进行关联,以确定死亡情况。从51个登记机构获取了2002年至2006年期间诊断并随访至2007年的患者数据。符合随访标准或至少与地方和国家死亡记录进行关联的登记机构,其年龄标准化的五年生存率估计值相当(所有部位和种族合并):SEER为63.9%,NPCR为63.1%,加拿大为62.6%。估计值因癌症部位而异。如果死亡确定完整且所有未死亡患者在研究期结束时均被假定存活,则使用不同随访程序的登记机构的生存数据具有可比性。